Hydroxychloroquine (HCQ) or corticosteroid therapy showed a trend toward a negative correlation with the IFN-I score (PRKR, IFIT1, and IFI44) in PBMCs of SLE patients [4]. Here, EIF2AK2 is linked to systemic lupus erythematosus.